cytarabine has been researched along with Coronary Artery Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amrein, PC; Attar, EC; Ballen, KK; Brunner, AM; Chen, YB; Drapkin, BJ; Fathi, AT; Feng, Y; McAfee, SL; Neuberg, DS; Sadrzadeh, H | 1 |
| Dartsch, PC; Hannekum, A; Hombach, V; Kochs, M; Roth, D; Seitzer, U; Voisard, R | 1 |
1 trial(s) available for cytarabine and Coronary Artery Disease
| Article | Year |
|---|---|
Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia.
Topics: Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Body Mass Index; Coronary Artery Disease; Cytarabine; Diabetes Mellitus; Disease-Free Survival; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Retrospective Studies; Risk Factors; Survival Rate | 2013 |
1 other study(ies) available for cytarabine and Coronary Artery Disease
| Article | Year |
|---|---|
The in-vitro effect of antineoplastic agents on proliferative activity and cytoskeletal components of plaque-derived smooth-muscle cells from human coronary arteries.
Topics: Aged; Antineoplastic Agents; Cell Division; Cells, Cultured; Coronary Artery Disease; Cytarabine; Cytoskeletal Proteins; Cytoskeleton; Doxorubicin; Female; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Recurrence; Vincristine | 1993 |